|
|
| Phases of Development | Discovery | Preclinical | Phase I | Phase I/II | Phase II | Phase II/III | Phase III | Approved | Marketed |
|---|
| Cancer | 1 | 6 | 10 | 4 | 13 | 1 | 6 | 2 | 3 | | Ophthalmic | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)